Court allows website blocking to tackle fake weight-loss drugs

A UK judge extends a blocking order aimed at ISPs including BT, EE, and Sky, allowing the maker of Ozempic and Wegovy to add infringing sites that sell counterfeits without returning to court.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@worldipreview.com

More on this story

Patents

Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’

10 February 2026 Telehealth platform faces legal action from the Danish pharma giant, as well as FDA pressure over GLP-1 drugs and a drop in shares after discontinuing new product.

Patents

How post-filing data rescued Novo Nordisk’s Ozempic patent in China

15 October 2024 The Beijing IP court’s decision to revive a key semaglutide patent based on experimental data has far-reaching legal and economic implications, says Jennifer Che of Eagle IP

The firms FIFA uses to defend its IP

UK court sets Warner and Paramount interim licence rate payable to Nokia

Coach drops Quince dupe lawsuit after Ugg verdict

UK director fails to move $45m trade secrets claim to Dubai

World Cup fakes spark global crackdown

Ugg owner v Quince: 5 takeaways for brands battling dupes

Quantum and photonics tech licensing expert joins EIP

Exclusive: ‘Cultural differences are an asset’ at the UPC

Court allows website blocking to tackle fake weight-loss drugs

More on this story

Editor's picks

Editor's picks

More articles